Share Us: Subscribe | Contact

Biblio

Export 3139 results:

Tagged

Author Title Type [ Year

]

2016

S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., “Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.

H. Leinonen, Lipponen, A., Gurevicius, K., and Tanila, H., “Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 51, no. 1, pp. 21-6, 2016.

I. Lazarou, Karakostas, A., Stavropoulos, T. G., Tsompanidis, T., Meditskos, G., Kompatsiaris, I., and Tsolaki, M., “A Novel and Intelligent Home Monitoring System for Care Support of Elders with Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1561-1591, 2016.

E. A. Tanifum, Ghaghada, K., Vollert, C., Head, E., Eriksen, J. L., and Annapragada, A., “A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 2, pp. 731-45, 2016.

J. Marín-Muñoz, Noguera-Perea, M. Fuensanta, Gómez-Tortosa, E., López-Motos, D., Antequera-Torres, M., Martínez-Herrada, B., Manzanares-Sánchez, S., Vivancos-Moreau, L., Legaz-García, A., Del Arroyo, A. Rábano- Gu, and Antúnez-Almagro, C., “Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 73-8, 2016.

M. Fà, Zhang, H., Staniszewski, A., Saeed, F., Shen, L. W., Schiefer, I. T., Siklos, M. I., Tapadar, S., Litosh, V. A., Libien, J., Petukhov, P. A., Teich, A. F., Thatcher, G. R. J., and Arancio, O., “Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.

M. A. Lovell, Lynn, B. C., Fister, S., Bradley-Whitman, M., M Murphy, P., Beckett, T. L., and Norris, C. M., “A Novel Small Molecule Modulator of Amyloid Pathology.”, J Alzheimers Dis, vol. 53, no. 1, pp. 273-87, 2016.

C. Sassi, Capozzo, R., Gibbs, R., Crews, C., Zecca, C., Arcuti, S., Copetti, M., Barulli, M. R., Brescia, V., Singleton, A. B., and Logroscino, G., “A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.”, J Alzheimers Dis, vol. 53, no. 2, pp. 475-85, 2016.

M. Cushman, Callas, P. W., McClure, L. A., Unverzagt, F. W., Howard, V. J., Gillett, S. R., Thacker, E. L., and Wadley, V. G., “N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 497-503, 2016.

A. Savastano, Klafki, H., Haußmann, U., Oberstein, T. Jan, Muller, P., Wirths, O., Wiltfang, J., and Bayer, T. A., “N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.”, J Alzheimers Dis, vol. 49, no. 1, pp. 101-10, 2016.

C. Sanders, Behrens, S., Schwartz, S., Wengreen, H., Corcoran, C. D., Lyketsos, C. G., and Tschanz, J. A. T., “Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.”, J Alzheimers Dis, vol. 52, no. 1, pp. 33-42, 2016.

M. Tombini, Sicari, M., Pellegrino, G., Ursini, F., Insardá, P., and Di Lazzaro, V., “Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1619-1627, 2016.

G. Tumminelli, Di Donato, I., Guida, V., Rufa, A., De Luca, A., and Federico, A., “Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene.”, J Alzheimers Dis, vol. 49, no. 1, pp. 27-30, 2016.

D. A. Nation, Ho, J., and Yew, B., “Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.”, J Alzheimers Dis, vol. 50, no. 3, pp. 779-89, 2016.

A. Oulhaj, Jernerén, F., Refsum, H., A Smith, D., and de Jager, C. A., “Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 2, pp. 547-57, 2016.

J. M. Robillard, “The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 11-3, 2016.

C. Lange, Suppa, P., Frings, L., Brenner, W., Spies, L., and Buchert, R., “Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.”, J Alzheimers Dis, vol. 49, no. 4, pp. 945-59, 2016.

S. Lim, Choi, J. Gyu, Moon, M., Kim, H. Geun, Lee, W., Bak, H. - R., Sung, H., Park, C. Hye, Kim, S. Yeou, and Oh, M. Sook, “An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice.”, J Alzheimers Dis, vol. 50, no. 1, pp. 189-200, 2016.

H. Marcel Joh Vanderstichele, Janelidze, S., Demeyer, L., Coart, E., Stoops, E., Herbst, V., Mauroo, K., Brix, B., and Hansson, O., “Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1121-32, 2016.

H. Hara, Ono, F., Nakamura, S., Matsumoto, S. - E., Jin, H., Hattori, N., and Tabira, T., “An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1047-1059, 2016.

J. Augusto Fe Cestari, Fabri, G. Maria Camp, Kalil, J., Nitrini, R., Jacob-Filho, W., de Siqueira, J. Tadeu Tess, and Siqueira, S. Regina D. T., “Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1479-85, 2016.

P. Banerjee, Sahoo, A., Anand, S., Bir, A., and Chakrabarti, S., “The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.

J. Antonio Allué, Sarasa, L., Izco, M., Pérez-Grijalba, V., Fandos, N., Pascual-Lucas, M., Ogueta, S., Pesini, P., and Sarasa, M., “Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 773-85, 2016.

Y. Manso, Comes, G., López-Ramos, J. C., Belfiore, M., Molinero, A., Giralt, M., Carrasco, J., Adlard, P. A., Bush, A. I., Delgado-García, J. María, and Hidalgo, J., “Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.

A. Malara, De Biase, G. Andrea, Bettarini, F., Ceravolo, F., Di Cello, S., Garo, M., Praino, F., Settembrini, V., Sgrò, G., Spadea, F., and Rispoli, V., “Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.

Pages